knowledge -WSS

knowledge

author：comprehensive 2025-10-01 21:09:52 - browse：3

President Joe Biden speaks at a campaign event at Pullman Yards on March 9, 2024 in Atlanta, Georgia. — President Biden speaks at a campaign event in Atlanta this month. Megan Varner/Getty Images

WASHINGTON — President Biden on Monday unveiled his requests for the 2025 budget, potentially his last chance to cement a legacy on drug costs, cancer research, and broad health care coverage.

The president’s $130.7 billion proposal is a dip from the $144.3 billion requested for this financial year and a nod to the tough line Congress has taken on government spending.

Biden also designed the plan to grab the attention of voters. While presidential budget proposals always include a long list of priorities that are unlikely to become law, Biden’s budget aims to show voters what they’d get in return for keeping him in office and voting in a Democratic-controlled Congress, including lower health care costs, expanded insurance coverage, and beefed up cybersecurity for hospitals.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Goldman Sachs launches $650M fund for life science investments

WSS

Readout Newsletter: The latest on Novo Nordisk, Alnylam, Apogee

A new approach to psychiatric drug development

Streamlined flu vaccines recommended by FDA advisory panel

Ozempic has benefits for kidney disease as well as diabetes

Ahead of JPM, here's who's profiting most in health care

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

hotspot

knowledge

knowledge

Activists slam private health insurers over coverage restrictions

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Biden's 'march

Supreme Court strikes down use of affirmative action

Burning questions for the 2024 JPM Healthcare Conference

Medical records are filled with copy

Goldman Sachs launches $650M fund for life science investments

Novavax promises a turnaround & Lilly roils the obesity market

A single drug, study failures leave Anavex with nothing but cash

hotspot

Federal weight loss drug coverage is 30 years out of date

GSK Flovent asthma inhalers replaced by authorized generics

The FDA must approve intranasal treatments for anaphylaxis

Readout Newsletter: BridgeBio, Akero, and human embryo models

Pregnant women don't need prenatal multivitamins, study concludes

First over

focus

knowledge

explore

explore